Suven Life Sciences

The granted claims of the patents from China, Israel, Mexico, Singapore, Sri Lanka include the class of selective 5-HT compounds…

The trial is being done for cognitive disorders in Alzheimer’s and Schizophrenia

Patents are for the treatment of disorders associated with neuro-degenerative diseases

These patents are the exclusive intellectual property of Suven and are achieved through internal discovery research efforts

Proposes a dividend of Re 0.60 per share Suven Life Sciences announced its audited financial results for the year ended March 31,…

These are useful in the treatment of cognitive impairment associated with neurodegenerative disorders Suven Life Sciences has…

Brand India Pharma was strongly represented by Indian pharma companies at various platforms

SUVN-G3031 is a potent, selective, brain penetrant and orally active Histamine H3 inverse agonist being developed for the…

The patents from the US and New Zealand are valid until 2030 and 2031

The granted claims of the patents include the class of selective alpha-4-beta-two compounds discovered by Suven and are being…